Pricing Log in Create free account

Cerus Corporation (CERS) vs NeuroPace, Inc. (NPCE)

Cerus Corporation and NeuroPace, Inc. are both Medical Devices companies. Cerus Corporation and NeuroPace, Inc. are of similar size ($435.6M and $430.2M). NeuroPace, Inc. grew revenue faster over the last twelve months: 11.6% against 11.4%. Cerus Corporation has the higher net margin (−2.90% vs −19.3%) and the higher return on invested capital (−1.87% vs −44.6%). Across the 18 metrics below, Cerus Corporation leads on 13 and NeuroPace, Inc. on 5.

Valuation

Metric CERS NPCE Medical Devices median
P/E n/m n/m 25.58
P/S 1.71 4.35 2.54
P/B 5.62 36.22 2.48
Price to free cash flow 869.48 n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 1.73 4.47 2.72
Earnings yield (1.77%) (4.52%) (12.82%)
Free cash flow yield 0.12% (2.70%) (8.18%)

Profitability

Metric CERS NPCE Medical Devices median
Gross margin 56.66% 81.57% 57.76%
Operating margin (0.98%) (13.87%) (15.07%)
Net margin (2.90%) (19.34%) (14.45%)
Free cash flow margin 0.20% (11.75%) (3.88%)
Return on equity (10.56%) (122.05%) (10.35%)
Return on assets (3.48%) (18.82%) (17.26%)
Return on invested capital (1.87%) (44.64%) (5.27%)

Growth

Metric CERS NPCE Medical Devices median
Revenue growth (TTM) 11.43% 11.59% 10.41%
EPS growth (last fiscal year) 27.27% 29.03% 28.17%
Revenue growth, 5-year CAGR 15.40% 19.44% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CERS NPCE Medical Devices median
Debt to equity 0.83 4.97 0.04
Current ratio 1.96 4.94 2.74
Net debt to EBITDA (0.14) 0.15 0.54

Dividend

Metric CERS NPCE Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric CERS NPCE Medical Devices median
Market cap 430.16m 435.58m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack